Leong, F J.(2014). A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers. Antimicrobial Agents and Chemotherapy, 58(10), 6209-6214. doi:10.1128/aac.03393-14

Leong, F. Joel. "A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers". Antimicrobial Agents and Chemotherapy, 58.10 ( 2014 ): 6209-6214.